Literature DB >> 7533561

Breast carcinoma: a collective disorder.

S Byers1, M Park, C Sommers, S Seslar.   

Abstract

The development and differentiation of the epithelial component of glandular tissues such as the breast is regulated by two apparently unrelated processes. One of these is presumed to be epithelial cell collective autonomous, that is, it is mediated by gene products which act directly on the epithelial cells. An important component of autonomous regulation is the functional expression of homotypic cell-cell adhesion molecules such as cadherins. The second process is non-autonomous and involves an inductive effect of the neighboring mesenchymal cell collective. An important component of non-autonomous regulation is the aggregation/condensation of mesenchyme closely associated with the epithelium. We propose that molecular alterations in autonomous and non-autonomous pathways are important causes and indicators respectively of breast cancer progression and that these two fundamental regulators of epithelial collective organization are in fact inter-dependent. For example, we show that the expression of hepatocyte growth factor (HGF), an epithelially targeted mesenchymally derived morphogenic factor is regulated by mesenchymal cell density (condensation) and by factors released from epithelial cells. Breast epithelial cells produce factors which inhibit and stimulate HGF expression. The inhibitory factor is transforming growth factor beta (TGF-beta) and the activation state of TGF-beta is a crucial element in HGF homeostasis. The balance of negative and positive HGF regulators is markedly affected by the growth conditions and differentiation state of the epithelial cells. The expression of the HGF receptor, met, is high in normal breast epithelial cells and in dedifferentiated (ER negative) tumor cells but is reduced or lost in ER positive well differentiated epithelial cells. Our results indicate that the expression of at least one epithelial morphogen, HGF, is inter-dependently regulated by mesenchymal condensation and by factors released by neighboring epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533561     DOI: 10.1007/bf00666154

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  73 in total

Review 1.  Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.

Authors:  R Clarke; R B Dickson; M E Lippman
Journal:  Crit Rev Oncol Hematol       Date:  1992-01       Impact factor: 6.312

2.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

3.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

Review 4.  The roles of epithelial-mesenchymal cell interactions in developmental processes.

Authors:  E J Sanders
Journal:  Biochem Cell Biol       Date:  1988-06       Impact factor: 3.626

5.  Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease.

Authors:  S L Schor; A M Schor; A Howell; D Crowther
Journal:  Exp Cell Biol       Date:  1987

6.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.

Authors:  R Chiquet-Ehrismann; P Kalla; C A Pearson
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

7.  Auto-induction of transforming growth factor-beta in human lung fibroblasts.

Authors:  J Kelley; S Shull; J J Walsh; K R Cutroneo; M Absher
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

8.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor.

Authors:  K Miyazawa; H Tsubouchi; D Naka; K Takahashi; M Okigaki; N Arakaki; H Nakayama; S Hirono; O Sakiyama; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

9.  Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.

Authors:  C Liu; M Park; M S Tsao
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  3 in total

1.  Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture.

Authors:  C Gache; Y Berthois; P M Martin; S Saez
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

2.  Hepatocyte growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells.

Authors:  Sheng-hua Chu; Yan-bin Ma; Hong Zhang; Dong-fu Feng; Zhi-an Zhu; Zhi-qiang Li; Xian-hou Yuan
Journal:  J Neurooncol       Date:  2007-04-27       Impact factor: 4.130

3.  Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.

Authors:  N Matsumoto-Taniura; K Matsumoto; T Nakamura
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.